Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed

Related Experiment Video

Updated: May 15, 2026

Separating Bacteria by Capsule Amount Using a Discontinuous Density Gradient
05:52

Separating Bacteria by Capsule Amount Using a Discontinuous Density Gradient

Published on: January 7, 2019

Alyssa S Shon1, Rajinder P S Bajwa, Thomas A Russo

  • 1Department of Medicine, University at Buffalo-State University of New York, Buffalo, NY, USA.

Virulence
|January 11, 2013
PubMed

Insights

A hypervirulent Klebsiella pneumoniae strain causes severe infections in healthy individuals. Intestinal colonization is a key step, but the infection route remains unclear, necessitating new diagnostic methods.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Epidemiology

Background:

  • A hypervirulent (hypermucoviscous) Klebsiella pneumoniae variant has emerged, causing severe community-acquired infections.
  • This pathogen affects younger, healthier hosts and can metastatically spread, unlike typical enteric Gram-negative bacilli.
  • Despite infecting a healthier population, significant morbidity and mortality are observed.

Purpose of the Study:

  • To describe the emergence and clinical features of hypervirulent Klebsiella pneumoniae.
  • To highlight the unusual metastatic potential and the need for improved diagnostics.
  • To discuss potential virulence factors and epidemiological considerations.

Main Methods:

  • Clinical case descriptions and epidemiological observations.
  • Comparison of virulence traits with classical Klebsiella pneumoniae strains.
  • Discussion of potential host-pathogen interactions and genetic factors.

Main Results:

  • The hypervirulent strain causes serious infections like liver abscess, pneumonia, meningitis, and endophthalmitis.
  • Intestinal colonization is identified as a critical step preceding infection.
  • Enhanced iron acquisition and increased capsule production are proposed virulence factors.

Conclusions:

  • Hypervirulent Klebsiella pneumoniae poses a significant public health threat, especially given potential antimicrobial resistance.
  • Further research is needed to elucidate the route of entry and host factors.
  • Development of objective diagnostic tests for routine clinical microbiology is crucial.
Keywords:
Klebsiella pneumoniaediagnosisepidemiologyhypermucoviscoushypervirulentinfectionpathogenesistreatmentvirulence factors

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...